Cargando…

Evaluation of autonomic function in children and adolescents with overactive bladder

AIMS: To evaluate autonomic activity in children/adolescents with isolated overactive bladder. MATERIALS AND METHODS: Descriptive, analytical, non-interventional, cross-sectional study conducted between February 2017 and January 2018 with individuals aged between 5 and 17 years old, with overactive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gondim, Rhaiana, Gorjão, Julia, Nacif, Ananda, Franco, Israel, Barroso, Ubirajara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Urologia 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486459/ https://www.ncbi.nlm.nih.gov/pubmed/34472767 http://dx.doi.org/10.1590/S1677-5538.IBJU.2021.0177

Ejemplares similares

Parasacral transcutaneous electrical nerve stimulation in children with overactive bladder: comparison between sessions administered two and three times weekly
por: Veiga, Maria Luiza, et al.
Publicado: (2021)

REPLY BY THE AUTHORS: RE: Parasacral transcutaneous electrical nerve stimulation in children with overactive bladder: comparison between sessions administered two and three times weekly
por: Veiga, Maria Luiza, et al.
Publicado: (2021)

Risk factors for urinary tract infection in children with urinary urgency
por: Gondim, Rhaiana, et al.
Publicado: (2018)

Enuresis and overactive bladder in children: what is the relationship between these two conditions?
por: Sousa, Ariane Sampaio, et al.
Publicado: (2016)

Urodynamic outcome of parasacral transcutaneous electrical neural stimulation for overactive bladder in children
por: Barroso, Ubirajara, et al.
Publicado: (2015)

Efficacy of tolterodine in children with overactive bladder
por: Koç, Başak, et al.
Publicado: (2020)

Efficacy and Safety of Propiverine in Children with Overactive Bladder
por: Kim, Woo Jung, et al.
Publicado: (2012)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

Diagnosis and Management of Bladder Dysfunction in Neurologically Normal Children
por: Fuentes, Mirgon, et al.
Publicado: (2019)

Effect of caffeine on bladder function in patients with overactive bladder symptoms
por: Lohsiriwat, Supatra, et al.
Publicado: (2011)

Mediterranean Diet and Overactive Bladder
por: Bozkurt, Yunus Erol, et al.
Publicado: (2022)

Urodynamic and Bladder Diary Factors Predict Overactive Bladder-wet in Women: A Comparison With Overactive Bladder-dry
por: Hsiao, Sheng-Mou, et al.
Publicado: (2019)

Onabotulinumtoxin A for Treating Overactive/Poor Compliant Bladders in Children and Adolescents with Neurogenic Bladder Secondary to Myelomeningocele
por: Marte, Antonio
Publicado: (2012)

Postmenopausal overactive bladder
por: Tomaszewski, Jacek
Publicado: (2014)

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
por: Tannenbaum, Stacey, et al.
Publicado: (2020)

OnabotulinumtoxinA for the treatment of neurogenic detrusor overactivity in children
por: Austin, Paul F., et al.
Publicado: (2020)

Overactive Bladder Successfully Treated with Duloxetine in a Female Adolescent
por: Wang, Sheng-Min, et al.
Publicado: (2015)

Autonomous Nervous System Activity in Women with Detrusor Overactivity
por: Im, Hyun Wook, et al.
Publicado: (2010)

Impact of overactive bladder on retrograde ejaculation
por: Salvarci, Ahmet, et al.
Publicado: (2018)

Clinical Correlation Between Overactive Bladder and Allergy in Children
por: Yin, Lu, et al.
Publicado: (2022)

Onabotulinumtoxin type A improves lower urinary tract symptoms and quality of life in patients with human T cell lymphotropic virus type 1 associated overactive bladder
por: Carneiro Neto, Jose Abraão, et al.
Publicado: (2018)

Prevalence, evaluation and management of overactive bladder in primary care
por: Cheung, Wellman W, et al.
Publicado: (2009)

Evaluation and management of overactive bladder: strategies for optimizing care
por: Willis-Gray, Marcella G, et al.
Publicado: (2016)

An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder
por: Frankel, Jeffrey, et al.
Publicado: (2022)

Pharmacologic management of overactive bladder
por: Lam, Sum, et al.
Publicado: (2007)

Medical management of overactive bladder
por: Ubee, Sarvpreet S., et al.
Publicado: (2010)

Overactive bladder in the vulnerable elderly
por: Wolff, Gillian F, et al.
Publicado: (2014)

Urinary biomarkers of overactive bladder
por: Tian, Xiao-Jun, et al.
Publicado: (2019)

Review of the epidemiology of overactive bladder
por: Eapen, Renu S, et al.
Publicado: (2016)

Impact of depression on overactive bladder
por: Kawahara, Takashi, et al.
Publicado: (2020)

Current pharmacotherapy of overactive bladder
por: Kreydin, Evgenyi I., et al.
Publicado: (2021)

Update on the management of overactive bladder
por: Fontaine, Christina, et al.
Publicado: (2021)

Telemedicine in Overactive Bladder Syndrome
por: Jericevic, Dora, et al.
Publicado: (2023)

Updates of Overactive Bladder in Pediatrics
por: Shim, Jisung, et al.
Publicado: (2023)

Evaluation of Overactive Bladder in Male Antidepressant Users: A Prospective Study
por: Solmaz, Volkan, et al.
Publicado: (2017)

Effects of overactive bladder syndrome on female sexual function
por: Lin, Xiao-Dan, et al.
Publicado: (2021)

STOMp: sexual function trial of overactive bladder medication
por: Polland, Allison, et al.
Publicado: (2023)

Impact of mirabegron versus solifenacin on autonomic function and arterial stiffness in female overactive bladder syndrome: a randomized controlled trial
por: Hsiao, Sheng-Mou, et al.
Publicado: (2022)

Management of neurogenic bladder dysfunction in children update and recommendations on medical treatment
por: Sager, Cristian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d7aa26hgniepgcrjpikraom87h